| Record ID | marc_loc_2016/BooksAll.2016.part17.utf8:185873096:1265 |
| Source | Library of Congress |
| Download Link | /show-records/marc_loc_2016/BooksAll.2016.part17.utf8:185873096:1265?format=raw |
LEADER: 01265cam a2200241 a 4500
001 86623205
003 DLC
005 20050503182657.0
008 870209s1986 cau s000 0 eng
010 $a 86623205
020 $c$8.00 (pbk.)
040 $aDLC$cDLC$dDLC
043 $an-us-ca
050 00 $aKFC10.3$b.M46 1986
082 00 $a362.2/93$219
110 1 $aCalifornia.$bLegislature.$bSenate.$bSubcommittee on Mental Health, Developmental Disabilities, and Genetic Diseases.
245 10 $aHearing before the Senate Subcommittee on Mental Health, Developmental Disabilities and Genetic Diseases :$bin re, PCP use, the medical and mental health implications : Isaac Newton Center Auditorium, 70 West Hedding Street, San Jose, California, Monday, July 14, 1986, 9:30 A.M. /$c[California Legislature, Senate Subcommittee on Mental Health, Developmental Disabilities and Genetic Diseases : Dan McCorquodale, chairman].
260 $aSacramento, CA (Box 90, State Capitol, Sacramento 95814) :$bThe Subcommittee :$bMay be purchased from Joint Publications,$c[1986]
300 $av leaves, 187 p. ;$c28 cm.
650 0 $aPhencyclidine.
650 0 $aDrug control$zCalifornia.
700 1 $aMcCorquodale, Dan.
740 0 $aPCP use, the medical and mental health implications.